🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will collect information on the safety of BNT162b2 products for ...
Status
Active Not Recruiting
Location
Pfizer
Start Date
2022-03-18
Trial ID
NCT05032976
Treatments Being Tested
The Omicron variant of concern (VOC) is currently rapidly spreading worldwi...
Status
Unknown
Location
Sheba Medical Center
Start Date
2021-12-27
Trial ID
NCT05231005
Treatments Being Tested
The purpose of this study was to understand whether participants could moun...
Status
Completed
Location
Novartis Investigative Site
Start Date
2021-04-19
Trial ID
NCT04792567
Treatments Being Tested
The SARS-CoV-2 virus causes severe respiratory illness and is an ongoing gl...
Status
Unknown
Location
Soroka UMC
Start Date
2022-01-06
Trial ID
NCT05516459
Treatments Being Tested
This is a Phase 3, randomized, observer-blind study in healthy individuals....
Status
Completed
Location
Kaiser Permanente Oakland
Start Date
2021-02-15
Trial ID
NCT04713553
Treatments Being Tested
The scope of this Phase I/II study is to determine whether GLB-COV2-043 is ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-02-21
Trial ID
NCT05602961
Treatments Being Tested
This clinical trial will be a blinded, randomised study to determine the sa...
Status
Withdrawn
Location
Royal Children's Hospital, Murdoch Children's Research Institute
Start Date
2022-05-02
Trial ID
NCT05543356
In this trial, we are evaluating the safety and tolerability of a new inves...
Status
Completed
Location
Scientia Clinical Research
Start Date
2021-06-21
Trial ID
NCT04742842
This trial consisted of three parts, Part A, Part B, and Part C, and evalua...
Status
Completed
Location
Collaborative Neuroscience Network LLC
Start Date
2021-08-25
Trial ID
NCT05004181
This study is to assess the post-marketing safety of BNT162b2 products usin...
Status
Completed
Location
Pfizer
Start Date
2025-04-23
Trial ID
NCT06743334